Market Place
Sourcing Support
After phase 2 data, Insilico plots pivotal lung disease trial
12 Nov 2024 //
FIERCE BIOTECH
Insilico Medicine`s AI Drug ISM001-055 Shows Phase IIa Success in IPF
18 Sep 2024 //
PR NEWSWIRE
Insilico nabs $500M+ biobucks deal for preclinical cancer asset
04 Jan 2024 //
FIERCE BIOTECH
First AI-generated small molecule drug enters Phase II trial
29 Jun 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
Insilico’s AI drug enters Phase II IPF trial
27 Jun 2023 //
CLINICAL TRIALS ARENA
Insilico Medicine to commence trials of ISM3312 in China to treat Covid-19
23 Feb 2023 //
CLINICAL TRIALS ARENA
AI-discovered drug receives US FDA orphan drug designation
09 Feb 2023 //
CPHI ONLINE
Insilico opens largest AI-powered biotech research centre in Middle East
03 Feb 2023 //
BIOSPECTRUM ASIA
Sanofi Reaffirms Commitment to AI Drug Discovery with $1.2B Insilico Pact
09 Nov 2022 //
BIOSPACE
Global AI player Insilico bumps up GSK vet to co-CEO in charge of development
16 Jun 2022 //
ENDPTS
Insilico Medicine raises $60 M to launch AI-powered drug discovery robotics lab
07 Jun 2022 //
BIOSPECTRUMASIA
Insilico nabs $60M with goal to be Big Pharma`s `Formula One`
06 Jun 2022 //
FIERCEBIOTECH
Insilico Medicine Raises $60M in Series D Financing
06 Jun 2022 //
PRNEWSWIRE
Insilico announces new preclinical candidate for Covid-19
25 May 2022 //
PHARMACEUTICAL-TECHNOLOGY
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate
24 May 2022 //
PRNEWSWIRE
Insilico Medicine expands synthetic lethality portfolio with PC candidate
05 May 2022 //
PRNEWSWIRE
Insilico Medicine Announces Advancement of Its Preclinical Candidate
13 Apr 2022 //
PRNEWSWIRE
Insilico Medicine enters research collaboration with the University of Zurich
09 Mar 2022 //
PRNEWSWIRE
Insilico Medicine Applauded by Frost & Sullivan for Enabling Drug Discovery
24 Jan 2022 //
PRNEWSWIRE
CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C
20 Jan 2022 //
GLOBENEWSWIRE
Fosun Pharma and Insilico team up in AI discovery deal
11 Jan 2022 //
ENDPTS
Insilico begins first human trial of AI-designed fibrosis drug
30 Nov 2021 //
FIERCEBIOTECH
PAQ Therapeutics Collaborate with Insilico Medicine to Develop Novel Therapies
09 Sep 2021 //
BIOSPACE
Huadong Medicine and Insilico Medicine enter co-development partnership
08 Sep 2021 //
PRNEWSWIRE
Insilico Medicine Appoints Dr. Robert Spiegel, MD, FACP, as acting CMO
02 Sep 2021 //
PRNEWSWIRE
Insilico, 4B Technologies team up for ALS drug discovery
27 Aug 2021 //
FIERCEBIOTECH
Insilico finds a new partner for AI drug discovery
20 Aug 2021 //
ENDPTS
Insilico’s AI engines churn out candidate for kidney fibrosis
04 Aug 2021 //
FIERCEBIOTECH
Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis
04 Aug 2021 //
PRNEWSWIRE
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship
02 Aug 2021 //
PRNEWSWIRE
Insilico nets $255M to put AI-made drugs through clinical trials
23 Jun 2021 //
FIERCEBIOTECH
Insilico nets $255M to put AI-made drugs through clinical trials
22 Jun 2021 //
FIERCEBIOTECH
Mark Mallon charts post-Ironwood course by taking CEO job at NeoGenomicS
26 Feb 2021 //
ENDPTS
Fierce Pharma Asia—Daiichi Sankyo`s new R&D head; Clover`s $230M
26 Feb 2021 //
FIERCEPHARMA
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate
24 Feb 2021 //
PRNEWSWIRE
Insilico preps first candidate for IND studies, hoping to launch trial in IPF
24 Feb 2021 //
ENDPTS
Insilico’s AI uncovers novel target, drug for pulmonary fibrosis
24 Feb 2021 //
FIERCE BIOTECH
Insilico & APRINOIA to discover next-gen compounds for neurodegenerative
31 Dec 2020 //
BIOSPECTRUMASIA
Insilico and APRINOIA to discover next-gen compounds for neurodegenerative
29 Dec 2020 //
BIOSPECTRUMASIA
Insilico announces AI-powered drug discovery collaboration with Janssen
11 Nov 2020 //
BIOSPECTRUMASIA
Insilico announces AI-powered drug discovery collaboration with Janssen
10 Nov 2020 //
BIOSPECTRUMASIA
Insilico announces a multi-target AI-powered drug discovery collB with Janssen
09 Nov 2020 //
PRNEWSWIRE
Insilico, Taisho form AI collab to tackle age-related diseases
16 Oct 2020 //
FIERCE BIOTECH
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
15 Oct 2020 //
PRNEWSWIRE
Insilico releases AI-powered platform for Novel Therapeutic Target Discovery
23 Sep 2020 //
PRNEWSWIRE
Insilico aging spinout Deep Longevity bought by Regent Pacific
03 Sep 2020 //
FIERCEBIOTECH
AI`s hunt for the molecule to stop COVID-19
20 Aug 2020 //
FIERCEBIOTECH
Boehringer Ingelheim adds second AI partner in a month
06 May 2020 //
ENDPTS
Astellas partners with Insilico, Harvard; Zambon gets FDA`s fast track status
28 Apr 2020 //
ENDPTS
Insilico inks another deal with Sino Biopharma ; Ramaswamy`s Datavant to invest
19 Mar 2020 //
ENDPTS
Insilico launches new brain cancer AI outfit led by GSK alum
27 Feb 2020 //
FIERCE BIOTECH
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
16 Jan 2020 //
XCONOMY
Insilico enters into research collaboration with Pfizer Inc
14 Jan 2020 //
PR NEWSWIRE
Insilico signs $200M AI drug discovery partnership with China`s CTFH
10 Oct 2019 //
FIERCE BIOTECH
